中国药业2012,Vol.21Issue(5):4-8,5.
左旋肉碱治疗非酒精性脂肪肝的系统评价
Systematic Review of L-Carnitine for Nonalcoholic Fatty Liver Disease
杨敏 1牟金金 2唐尧1
作者信息
- 1. 四川大学华西医院药剂科,四川成都,610041
- 2. 四川大学华西药学院,四川成都,610041
- 折叠
摘要
Abstract
Objective To assess the efficiency and safety of L - carnitine for nonalcoholic fatty liver disease. Methods Searching for allMeta - analysis. Results The total effective rate,TC decrease,TG decrease of L - carnitine single group has no statistical significance, while drug combination group has statistical significance. ALT decrease, AST decrease of Both the L - carnitine sinlge group and drug combination group have statistical significance. There is no statistically significant difference in the category of the incidence of advert reaction. Conclusion L- carnitine is effective and safe for nonalcoholic fatty liver disease, given that it is combined with other positive agent for better impact.关键词
左旋肉碱/非酒精性脂肪肝/系统评价/Meta分析Key words
L - carnitine/ nonalcoholic fatty liver disease/ systematic review/ Meta - analysis分类
医药卫生引用本文复制引用
杨敏,牟金金,唐尧..左旋肉碱治疗非酒精性脂肪肝的系统评价[J].中国药业,2012,21(5):4-8,5.